RecruitingNot ApplicableNCT05318222

Genetic Inclusion by Virtual Evaluation

Virtual Platforms for Genetics Evaluation in the Medically Underserved

Sponsor

Baylor College of Medicine

Enrollment

200 participants

Start Date

Jun 1, 2022

Study Type

INTERVENTIONAL

Conditions

Neurodevelopmental Disorders Birth Defects Multiple Congenital Anomaly

Summary

This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagene to provide remote evaluation and genomic sequencing for improving genetic health of less resourced children with rare disorders living along the Texas-Mexico border.

Eligibility

Min Age: 1 DayMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Whole genome sequencing (WGS) for people with birth defects, multiple congenital anomaly, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTWhole genome sequencing (WGS)

WGS will identify copy number variations (CNVs), single nucleotide variants (SNVs), as well as triplet repeat disorders in children with rare diseases